Combined Lorlatinib, Dabrafenib, and Trametinib Treatment for ROS1-Rearranged Advanced Non-Small-Cell Lung Cancer with a Lorlatinib-Induced BRAF V600E Mutation: A Case ReportDan Li, Yudong Wang, Xue Zhang et al.|Cancer Management and Research|2022Cited by 5